Please select the option that best describes you:

How do you discuss harms of MGUS screening with other medical providers?  

For example, how do you address tendency to "over-order" these tests in patients with common aches/pains but no structural abnormalities on advanced imaging? Or in patients with longstanding CKD that's not changing over years?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Medical University of South Carolina
Yes, it always comes to trade-offs between the soc...
Medical Oncologist at Kaiser Permanente
Thank you very much for your insight, Dr. @Banerje...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Excellently said on all fronts! The other interest...
Sign in or Register to read more